AKT1 and diffuse large B-cell lymphoma: Furthermore, a recent study by Zhong et al. demonstrated that inhibition of LDLR can promote ferroptosis through the PI3K/AKT pathway in diffuse large B-cell lymphoma (DLBCL) [156].